A National Patient Safety Alert has been issued warning of an impending shortage of specific medicines for Attention Deficit and Hyperactivity Disorders (ADHD).
The supply disruption of these products is attributed to the combined effect of manufacturing issues and increased global demand. Some ADHD products remain available but at insufficient quantities necessary to meet the insurmountable increases in demand. Current expectations are that supply disruptions may resolve at various dates . A Medicines Supply Tool by Specialist Pharmacy Services (SPS) which uses content from Department of Health and Social Care (DHSC) & Commercial Medicines Unit provides latest information on supply issues, recommended actions, alternative options, and expected resolution dates can be accessed here. Please note registration is required to access this tool. It is a national resource, and may not reflect local variations due to various reasons
ADHD
